相关实验视频

Updated: Aug 4, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K

恶性瘤和分子变化的概率,根据ThyroSeq v3基因组分类器在贝塞斯达的第四类IV类基因组分类器确定

Youley Tjendra1, Darcy A Kerr2,3, Yiqin Zuo1

  • 1Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.

Cancer cytopathology
|June 26, 2023
PubMed
概括

甲状腺Seq分子测试揭示了贝塞斯达类别IV甲状腺结节中明显的分子概况. 瘤细胞毛囊瘤 (OFN) 与毛囊瘤 (FN) 相比,具有较低的恶性瘤风险和不同的变化.

关键词:
在BRAF G466RR中使用.贝塞斯达 (Bethesda) 是第四类的城市.在MDROM中,MDROM是MDROM.这就是POMOM的意义.ThyroSeq v3 GC GC Seq GC Seq v3 GC Seq GC Seq GC Seq v3 GC Seq GC Seq GC Seq v3 GC Seq GC Seq v3 GC Seq GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC Seq v3 GC毛囊性新生体的发生.

更多相关视频

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

563
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

相关概念视频

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...